ID   2A9
AC   CVCL_B0JX
DR   Wikidata; Q108819510
RX   Patent=WO2000035483A1;
RX   PubMed=10793066;
RX   PubMed=11991814;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12620.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11226; Human MBL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=WO2000035483A1;
RA   Stahl G.L., Collard C.D.;
RT   "Methods and products for regulating lectin complement pathway
RT   associated complement activation.";
RL   Patent number WO2000035483A1, 22-Jun-2000.
//
RX   PubMed=10793066; DOI=10.1016/S0002-9440(10)65026-2;
RA   Collard C.D., Vakeva A., Morrissey M.A., Agah A., Rollins S.A.,
RA   Reenstra W.R., Buras J.A., Meri S., Stahl G.L.;
RT   "Complement activation after oxidative stress: role of the lectin
RT   complement pathway.";
RL   Am. J. Pathol. 156:1549-1556(2000).
//
RX   PubMed=11991814; DOI=10.1089/15368590252917610;
RA   Zhao H., Wakamiya N., Suzuki Y., Hamonko M.T., Stahl G.L.;
RT   "Identification of human mannose binding lectin (MBL) recognition
RT   sites for novel inhibitory antibodies.";
RL   Hybrid. Hybridomics 21:25-36(2002).
//